Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • xiao
    Junior Member
    • Sep 2015
    • 4

    #1

    TE-tracker: cannot use slclust

    Hi, everyone!

    I recently want to use TE-Tracker (http://www.genoscope.cns.fr/externe/tetracker/) to identify transposon , But when I run leto.pl, somethings is wrong!

    The key of error is the 219 lines of leto.pl :

    `$SLC -i $dir/$file -o $OUTPUT_DIR/$file.clustered -l $x_lim -n $y_lim -m $min_pair -t 0 -r $read_length`



    I think author want to use a programe named 'slclust' to deal with data, But 'slclust' that download from 'http://sourceforge.net/projects/slclust/' cannot run as this command, it only have a argument '-j';
    why? and what i should do to solve this problem?

    Thanks!
  • dgscofield
    Member
    • Nov 2010
    • 28

    #2
    I asked the developers the same question back in February ([email protected]). The slclust used is not the sourceforge one, it is their own program.

    They sent me a copy, so perhaps you could email them as well. Hopefully they will add it to the downloadable tarball.

    Comment

    • xiao
      Junior Member
      • Sep 2015
      • 4

      #3
      I email them ,but no reply . So, can you forward the email to me (qiwang1993 at gmail.com). Thanks, dgscofield.

      Comment

      • dgscofield
        Member
        • Nov 2010
        • 28

        #4
        No, I'm sorry I can't send it to you. You can see for yourself that the software includes no explicit license file nor license within any of the source files, so neither I nor other users have been given permission to redistribute the software as is common with many licenses including GPL. Additionally, the "official" distribution site is still available.

        The email of the user who sent me slclust is [email protected].

        Comment

        • xiao
          Junior Member
          • Sep 2015
          • 4

          #5
          OK! Thank you very much ! I'll write another letter to [email protected] !
          Best wishes!

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Today, 02:55 AM
          0 responses
          5 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          11 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          12 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          24 views
          0 reactions
          Last Post SEQadmin2  
          Working...